Using the MADIT II Criteria for Implantable Cardioverter Defibrillators—What is the Role of the Food and Drug Administration Approval?
Helen S. BaroldVolume:
7
Language:
english
Pages:
4
DOI:
10.1023/b:cepr.0000023166.65777.6f
Date:
December, 2003
File:
PDF, 68 KB
english, 2003